Rewalk Robotics Ltd (FRA:2RW)
€ 4 0 (0%) Market Cap: 39.71 Mil Enterprise Value: 22.07 Mil PE Ratio: 0 PB Ratio: 0.59 GF Score: 55/100

Rewalk Robotics Ltd Medicare Proposal Discussion Transcript

Jul 11, 2023 / 12:30PM GMT
Release Date Price: €5.09 (+4.91%)
Operator

Good day, and welcome to the ReWalk Robotics Medicare Proposal to Establish Personal Exoskeletons within a Benefit Category for Eligible Beneficiaries Conference Call. (Operator Instructions) Please note today's event is being recorded. I would now like to turn the conference over to Mike Lawless, Chief Financial Officer. Please go ahead, sir.

Michael A. Lawless
ReWalk Robotics Ltd. - CFO

Thank you, Rocco. Good morning, and welcome to our conference call to discuss the recent CMS proposal to establish personal exoskeletons within a Medicare benefit category. I'm Mike Lawless, ReWalk Robotics' Chief Financial Officer. And with me on today's call is Larry Jasinski, ReWalk's Chief Executive Officer; Jeannine Lynch, ReWalk's Vice President, Strategy and Market Access; and Ashley Barnes, an advocate for the spinal cord injured community and a ReWalk user. Before we get started, I would like to remind everyone that any statements made on today's conference call that express a belief, expectation, projection, forecast, anticipation or intent regarding future events

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot